MARKET

AIM

AIM

Aim Immunotech
AMEX
9.25
+0.60
+6.87%
After Hours: 9.09 -0.16 -1.73% 16:33 07/18 EDT
OPEN
8.92
PREV CLOSE
8.66
HIGH
9.25
LOW
8.50
VOLUME
8.59K
TURNOVER
--
52 WEEK HIGH
42.95
52 WEEK LOW
2.510
MARKET CAP
7.07M
P/E (TTM)
-0.3779
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AIM last week (0707-0711)?
Weekly Report · 5d ago
Weekly Report: what happened at AIM last week (0630-0704)?
Weekly Report · 07/07 10:15
AIM ImmunoTech presents on potential of private-public partnerships for oncology
TipRanks · 07/02 13:00
Weekly Report: what happened at AIM last week (0623-0627)?
Weekly Report · 06/30 10:18
Weekly Report: what happened at AIM last week (0616-0620)?
Weekly Report · 06/23 10:15
AIM ImmunoTech Faces NYSE Noncompliance Notification
TipRanks · 06/20 21:19
AIM ImmunoTech receives noncompliance notification from NYSE
TipRanks · 06/20 20:30
AIM ImmunoTech Announces NYSE American Notice of Noncompliance With Minimum Stockholders’ Equity Requirements
Barchart · 06/20 15:15
More
About AIM
AIM ImmunoTech Inc. is an immuno-pharma company. The Company is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon alfa). Ampligen is a double-stranded RNA (dsRNA) and highly selective TLR3 agonist immuno-modulator, which is being developed for globally important cancers, viral diseases and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe chronic fatigue syndrome (CFS). Alferon N Injection is an injectable formulation of natural alpha interferon, which is approved for sale in the United States and Argentina for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older.

Webull offers AIM ImmunoTech Inc stock information, including AMEX: AIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AIM stock methods without spending real money on the virtual paper trading platform.